A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis

Vascular Endothelial Growth Factor (VEGF) promotes angiogenesis in tumours of various cancers. Monoclonal antibodies and nanobodies are one of the potent agents in the treatment of cancer. Due to their high costs, researchers are considering to design and produce peptides as a substitute approach in...

Descripción completa

Detalles Bibliográficos
Autores principales: Karami, Elmira, Sabatier, Jean-Marc, Behdani, Mahdi, Irani, Shiva, Kazemi-Lomedasht, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717616/
https://www.ncbi.nlm.nih.gov/pubmed/32441172
http://dx.doi.org/10.1080/14756366.2020.1758690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717616/
https://www.ncbi.nlm.nih.gov/pubmed/32441172
http://dx.doi.org/10.1080/14756366.2020.1758690

Ejemplares similares